-
1Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patientsWeitere Verfasser: “...Yoshinaka, Ryoji...”
Aufsatz -
2Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patientsWeitere Verfasser: “...Yoshinaka, Ryoji...”
Aufsatz